Skip to content
healthcare.dev

Amantadine Hydrochloride

NDC 10135-692, Amantadine Hydrochloride, tablet, from Marlex Pharmaceuticals Inc.

Product NDC
10135-692
Status
Listed
Labeler
Marlex Pharmaceuticals Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMANTADINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]

Package NDCNDC-11Package
10135-692-0110135069201100 TABLET in 1 BOTTLE (10135-692-01)
10135-692-0510135069205500 TABLET in 1 BOTTLE (10135-692-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/25af52ee-9b29-4c07-a383-62d4537b63e0

Use it

Look up 10135-692 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-692. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.